By Debra Sherman CHICAGO, Jan 20 (Reuters) - Guidant Corp.'s (GDT.N: , , ) legal woes and worsening public image are not expected to deter Johnson & Johnson (JNJ.N: , , ) or Boston Scientific Corp. (

http://c.moreover.com/click/here.pl?r455869380